SNPMiner Trials by Shray Alag


SNPMiner SNPMiner Trials (Home Page)


Report for Mutation M1040E

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

There is one clinical trial.

Clinical Trials


1 AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities

This prospective cohort study seeks to determine if the ECHO-CT program, a healthcare videoconferencing program, can improve clinical outcomes while reducing cost and resource utilization when expanded to a community hospital setting. Data will be analyzed on the facility level and patient level.

NCT03832257 Acute Disease Other: ECHO CT Intervention Other: Matched Non-Participating Facilities
MeSH: Acute Disease

From the MDS (variable codes in parentheses), including rates of dehydration (J1550C), internal bleeding (J1550D), falls (J1800), anti-psychotic medication use (N0400A), delirium (C1300), surgical wound infections (I2500 and M1040E), pressure ulcers (M0210), and uncontrolled pain (J0850).. Health Care Cost. --- M1040E ---

Primary Outcomes

Description: Number of hospital readmissions over 30 day period among participating SNF sites

Measure: 30-Day Readmission Rates

Time: 30-Days

Secondary Outcomes

Description: Includes average length of stay in the facility

Measure: Health Care Utilization

Time: up to 90 days

Description: From the MDS (variable codes in parentheses), including rates of dehydration (J1550C), internal bleeding (J1550D), falls (J1800), anti-psychotic medication use (N0400A), delirium (C1300), surgical wound infections (I2500 and M1040E), pressure ulcers (M0210), and uncontrolled pain (J0850).

Measure: Incidence of Adverse Clinical Conditions

Time: 30 Days

Description: Total 30-day Medicare costs for fee-for-service patients.

Measure: Health Care Cost

Time: 30-days


HPO Nodes